Heparin-stabilised iron oxide for MR applications: a relaxometric study.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Superparamagnetic nanoparticles are used as MRI contrast agents but face challenges with efficacy and safety, including haemagglutination.
• Heparin is a clinically approved anticoagulant with potential as a stabilizing agent for nanoparticles.

Purpose of the Study:

• To develop stable superparamagnetic magnetite nanoparticles with enhanced MRI contrast capabilities.
• To address safety concerns associated with nanoparticle use in biomedical applications, specifically thrombosis.
• To explore the potential of heparin as a templating stabilizer for magnetite nanoparticles.

Main Methods:

• In situ preparation of magnetite nanoparticle colloids templated with heparin.
• Relaxometric investigations using nuclear magnetic resonance dispersion (NMRD) techniques.
• Single field r1 and r2 relaxation measurements to assess MRI contrast capabilities.
• Evaluation of protein-adsorption triggered thrombosis prevention.

Main Results:

• Stable magnetite nanoparticle colloids were prepared using heparin as a templating stabilizer.
• The nanoparticles exhibited exceptionally strong MRI contrast, particularly at low fields.
• Heparin templating enhanced interparticle interactions, leading to strong magnetic anisotropic behavior.
• The nanocomposites effectively prevented protein-adsorption triggered thrombosis.

Conclusions:

• Heparin-stabilized magnetite nanoparticles offer superior MRI contrast and improved safety profiles.
• These nanoparticles demonstrate significant potential for in vivo MRI diagnostics.
• The developed nanocomposites overcome limitations of previous nanoparticle contrast agents.